Epigenetics and ncRNAs in Brain Function and Disease: Mechanisms and Prospects for Therapy

被引：0
作者：
Miguel A. Varela
Thomas C. Roberts
Matthew J. A. Wood
机构：
[1] University of Oxford,Department of Physiology, Anatomy and Genetics
[2] The Scripps Research Institute,Department of Molecular and Experimental Medicine
来源：
Neurotherapeutics | 2013年 / 10卷
关键词：
Epigenetics; Cancer; miRNA; ncRNA; Neurodegeneration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The most fundamental roles of non-coding RNAs (ncRNAs) and epigenetic mechanisms are the guidance of cellular differentiation in development and the regulation of gene expression in adult tissues. In brain, both ncRNAs and the various epigenetic gene regulatory mechanisms play a fundamental role in neurogenesis and normal neuronal function. Thus, epigenetic chromatin remodelling can render coding sites transcriptionally inactive by DNA methylation, histone modifications or antisense RNA interactions. On the other hand, microRNAs (miRNAs) are ncRNA molecules that can regulate the expression of hundreds of genes post-transcriptionally, typically recognising binding sites in the 3′ untranslated region (UTR) of mRNA transcripts. Furthermore, there are a myriad of interactions in the interface of miRNAs and epigenetics. For example, epigenetic mechanisms can silence miRNA coding sites, and miRNAs can be the effectors of transcriptional gene silencing, targeting complementary promoters or silencing the expression of epigenetic modifier genes like MECP2 and EZH2 leading to global changes in the epigenome. Alterations in this regulatory machinery play a key role in the pathology of complex disorders including cancer and neurological diseases. For example, miRNA genes are frequently inactivated by epimutations in gliomas. Here we describe the interactions between epigenetic and ncRNA regulatory systems and discuss therapeutic potential, with an emphasis on tumors, cognitive disorders and neurodegenerative diseases.
引用
收藏
页码：621 / 631
页数：10
相关论文
共 629 条
  • [21] Edvinsson S(2009)MicroRNAs: key regulators of stem cells Nat Rev Mol Cell Biol 10 116-33
  • [22] Grossniklaus U(2008)Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells Cell 134 521-61
  • [23] Kelly B(2009)Embryonic stem cell-specific microRNAs promote induced pluripotency Nat Biotechnol 27 459-8
  • [24] Ferguson-Smith AC(2011)Silencing of microRNA families by seed-targeting tiny LNAs Nat Genet 43 371-46
  • [25] Pembrey M(2009)Molecular epigenetics and genetics in neuro-oncology Neurother 6 436-12
  • [26] Lindquist S(2000)Molecular-clinical spectrum of the ATR-X syndrome Am J Med Genet 97 204-20
  • [27] Heijmans BT(2004)Prader-Willi syndrome: advances in genetics, pathophysiology and treatment Trends Endocrinol Metab 15 12-8
  • [28] Tobi EW(1999)Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 Nat Genet 23 185-1000
  • [29] Stein AD(2010)Regulation of alternative splicing by histone modifications Science 327 996-26
  • [30] Putter H(2012)Epigenetic control of alternative mRNA processing at the imprinted Herc3/Nap1l5 locus Nucleic Acids Res 40 8917-95
12345678910